JANE STREET GROUP, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 226 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,033,268
+43.5%
37,478
+56.4%
0.00%
Q2 2023$720,268
+22.2%
23,961
+47.3%
0.00%
Q1 2023$589,535
+69.0%
16,272
+66.4%
0.00%
Q4 2022$348,853
+64.6%
9,780
+55.9%
0.00%
Q3 2022$212,000
-58.5%
6,274
-64.5%
0.00%
Q2 2022$511,000
-82.1%
17,668
-80.0%
0.00%
-100.0%
Q1 2022$2,854,000
-14.8%
88,293
-23.1%
0.00%0.0%
Q4 2021$3,349,000
+1250.4%
114,829
+1134.7%
0.00%
Q3 2021$248,000
-55.2%
9,300
-48.3%
0.00%
Q2 2021$554,000
-30.4%
18,000
-40.8%
0.00%
Q1 2021$796,000
-39.9%
30,402
-42.2%
0.00%
Q4 2020$1,325,000
+22.5%
52,632
+15.4%
0.00%
-100.0%
Q4 2019$1,082,000
+403.3%
45,616
+483.0%
0.00%
Q3 2019$215,000
-22.9%
7,824
-7.1%
0.00%
Q2 2019$279,000
-78.3%
8,425
-77.0%
0.00%
-100.0%
Q1 2019$1,285,000
-45.5%
36,645
-48.4%
0.00%
-60.0%
Q4 2018$2,359,000
+148.1%
70,991
+275.9%
0.01%
+150.0%
Q3 2018$951,000
+17.0%
18,887
+39.1%
0.00%0.0%
Q2 2018$813,000
-45.8%
13,579
-63.8%
0.00%
-60.0%
Q3 2017$1,501,000
+544.2%
37,534
+595.7%
0.01%
+400.0%
Q2 2017$233,000
+56.4%
5,395
-51.3%
0.00%0.0%
Q4 2015$149,000
-60.4%
11,083
-64.4%
0.00%
-66.7%
Q1 2015$376,000
-65.4%
31,113
-68.7%
0.00%
-78.6%
Q2 2014$1,087,000
+391.9%
99,268
+301.4%
0.01%
+600.0%
Q1 2014$221,00024,7310.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders